Cerebral cysts

G6_CERCYST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G93 Hospital discharge: ICD-9 — 3480 Cause of death: ICD-10 — G93 Cause of death: ICD-9 — 3480 2 out of 7 registries used, show all original rules.	2735
4. Check minimum number of events None	2735
5. Include endpoints None	2735
6. Filter based on genotype QC (FinnGen only)	2454

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Aliae morbositates cerebri

NAME	G6_CERCYST
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G93
HD_ICD_9	3480
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G93
COD_ICD_9	3480
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cerebral cysts based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Postviral fatigue syndrome

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20739	9226	11265
Only index persons	15721	7529	8192
Unadjusted period prevalence (%)
Whole population	0.29	0.26	0.31
Only index persons	0.30	0.28	0.31
Median age at first event (years)
Whole population	52.04	47.69	55.28
Only index persons	49.56	44.95	53.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2454	1376	1078
Unadjusted period prevalence (%)	0.49	0.49	0.49
Median age at first event (years)	50.24	42.64	59.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2540: Matched controls
25400

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G93.2

ICD-10 Finland

Benign intracranial hypertension

4748.1

307.7

412

S01EC01

ATC

acetazolamide; systemic

20.9

307.7

328

179

H47.1

ICD-10 Finland

Papilloedema, unspecified

65.5

307.7

216

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

39.9

307.7

337

G93.0

ICD-10 Finland

Cerebral cysts

4087.6

307.7

645

G93.4

ICD-10 Finland

Encephalopathy, unspecified

3905.4

307.7

350

G93.3

ICD-10 Finland

Postviral fatigue syndrome

141.7

307.7

354

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

6368.7

307.7

522

TAB00

NOMESCO Finland

Lumbar puncture

8.6

257.1

355

472

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.0

252.9

517

1040

AA1AD

NOMESCO Finland

CT of head and brain

3.7

214.3

987

3689

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.6

173.3

474

1203

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

145.7

383

936

R51.80

ICD-10 Finland

Headache

3.3

145.4

692

2554

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

16.9

143.8

121

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.0

127.1

203

313

XA800

NOMESCO Finland

Neuropsychological investigation

5.6

115.0

231

446

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

18.1

112.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

109.8

572

2190

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

106.5

629

2578

WX730

NOMESCO Finland

Conventional respirator

11.3

105.6

112

103

N03AX11

ATC

topiramate; oral

6.6

100.3

167

268

N03AX14

ATC

levetiracetam; systemic

6.2

92.5

163

277

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.4

90.3

239

580

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

298.4

85.2

A07AA11

ATC

rifaximin; oral

28.6

83.2

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

13.9

82.9

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.6

82.3

135

213

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.0

81.2

248

669

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

81.0

249

675

G93.6

ICD-10 Finland

Cerebral oedema

+∞

79.6

G93.99

ICD-10 Finland

Disorder of brain, unspecified

781.7

77.7

XCK00

NOMESCO Finland

Perimetry

4.1

74.3

219

575

G93.8

ICD-10 Finland

Other specified disorders of brain

378.1

74.1

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.0

71.9

111

164

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

71.3

219

592

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.4

69.6

267

838

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

69.4

399

1583

N06AX16

ATC

venlafaxine; oral

2.5

67.8

492

2190

F48.0

ICD-10 Finland

Neurasthenia

28.0

64.9

N03AG01

ATC

valproic acid; systemic, rectal

3.4

62.6

237

736

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.0

62.5

301

1081

R53

ICD-10 Finland

Malaise and fatigue

2.1

61.1

780

4390

N03AF02

ATC

oxcarbazepine; oral

4.6

60.5

147

332

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

9.5

60.3

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.5

59.0

150

351

G93.90

ICD-10 Finland

Brain death

+∞

57.5

N05AH04

ATC

quetiapine; oral

2.2

57.2

582

2985

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

57.0

659

3554

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

5.5

55.9

110

207

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.1

55.7

169

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

53.2

444

2088

WX872

NOMESCO Finland

Intensive care

3.7

52.9

177

506

N03AX12

ATC

[U] gabapentin; oral

2.3

52.6

446

2112

N06AX21

ATC

duloxetine; oral

2.5

52.0

373

1637

N03AX18

ATC

lacosamide; systemic

10.0

51.7

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.0

51.5

152

398

N03AX16

ATC

[U] pregabalin

2.1

51.4

592

3173

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.4

50.2

128

300

C03CA01

ATC

furosemide; systemic

2.0

50.1

683

3892

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

135.3

50.0

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

8.4

49.7

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

7.3

49.7

102

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

49.3

442

2139

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

48.7

190

600

G44.2

ICD-10 Finland

Tension-type headache

2.3

48.4

427

2050

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

48.1

273

1066

N06AX11

ATC

mirtazapine; oral

1.9

47.5

908

5784

R42

ICD-10 Finland

Dizziness and giddiness

2.1

47.4

585

3206

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.7

47.3

117

G41.9

ICD-10 Finland

Status epilepticus, unspecified

13.6

46.8

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.0

46.5

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

19.2

45.8

N05BA09

ATC

clobazam; oral

10.6

45.6

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.8

45.4

252

972

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

455.7

45.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

45.0

728

4376

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

44.9

N06AB04

ATC

citalopram; systemic

2.1

44.6

552

3021

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

44.4

247

954

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

9.5

43.7

Z2445

NOMESCO Finland

Psychologist

3.4

43.7

165

510

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

43.2

245

955

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

42.9

1127

7846

N05BA04

ATC

oxazepam; oral

1.9

42.6

702

4232

G93.5

ICD-10 Finland

Compression of brain

+∞

41.8

G43.3

ICD-10 Finland

Complicated migraine

4.8

41.5

204

R41.0

ICD-10 Finland

Disorientation, unspecified

4.5

41.3

102

233

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.6

41.1

262

1082

N28

ICPC

Limited function/disability (N)

5.6

41.0

142

C07AB07

ATC

bisoprolol; oral

1.8

41.0

1088

7567

CS494

NOMESCO Finland

Other visual field testing

4.7

40.8

207

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

40.5

387

1911

N03AX09

ATC

lamotrigine; oral

3.0

40.4

192

680

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.0

39.7

180

C07AA05

ATC

propranolol; systemic

2.0

39.5

570

3277

A06AD11

ATC

lactulose; oral

2.2

39.3

364

1773

N05BA01

ATC

diazepam; systemic, rectal

2.3

39.0

344

1643

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

38.8

210

798

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

6.9

38.7

3480A

ICD-9 Finland

Other conditions of brain, Cerebral cysts

+∞

38.6

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

37.5

255

1085

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.4

36.8

276

1227

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.8

36.2

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

362.3

36.1

N03AE01

ATC

clonazepam; systemic

3.0

36.1

172

610

183

Kela drug reimbursment

Lamotrigin and topiramate

7.1

35.6

N29

ICPC

Neurological sympt/complt other

4.9

35.4

166

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

35.4

291

1347

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

35.1

148

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

34.4

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

34.4

434

2370

N06AX12

ATC

bupropion; oral

2.3

33.8

265

1200

M03BX01

ATC

baclofen; systemic

4.7

33.5

170

GBB00

NOMESCO Finland

Tracheostomy

6.3

33.4

A28

ICPC

Limited function/disability NOS

2.0

33.2

396

2117

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

33.1

154

538

H02AB09

ATC

hydrocortisone; systemic

4.0

32.6

246

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

32.5

216

908

L28

ICPC

Limited function/disability (L)

2.0

32.4

436

2431

SPAT1301

SPAT

No procedures

1.7

32.0

757

5016

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

31.9

395

2140

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.0

31.7

138

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

31.6

193

778

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.2

31.5

208

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

31.3

M35.7

ICD-10 Finland

Hypermobility syndrome

4.9

31.0

141

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

316.7

30.9

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

316.7

30.9

N05CF01

ATC

zopiclone; oral

1.7

30.8

741

4922

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.8

30.8

261

H53.4

ICD-10 Finland

Visual field defects

4.7

30.2

156

N06AB06

ATC

sertraline; oral

2.0

30.1

343

1801

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.7

30.0

149

PA2AD

NOMESCO Finland

CT angiography of brain

6.9

29.7

H53.2

ICD-10 Finland

Diplopia

3.5

29.7

103

301

N02AX02

ATC

tramadol; systemic, rectal

1.6

29.6

993

7173

N06AB10

ATC

escitalopram; oral

1.8

29.5

577

3608

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

29.4

122

399

WX930

NOMESCO Finland

Thepapeutic hypothermia

37.5

29.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

29.2

543

3346

C03DA01

ATC

spironolactone; oral

2.1

29.1

293

1468

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

295.2

28.8

N03AF01

ATC

carbamazepine; oral, rectal

2.9

28.7

140

502

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

28.3

262

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

28.1

377

2093

R55

ICD-10 Finland

Syncope and collapse

2.2

28.0

269

1323

R50.9

ICD-10 Finland

Fever, unspecified

1.9

27.8

431

2508

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.8

27.8

R06.0

ICD-10 Finland

Dyspnoea

1.7

27.2

642

4218

N04BC09

ATC

rotigotine; transdermal

10.5

27.1

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

10.5

27.1

N06AX26

ATC

vortioxetine; oral

2.2

27.1

244

1168

R11

ICD-10 Finland

Nausea and vomiting

2.2

26.6

254

1245

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

26.6

151

587

R18

ICD-10 Finland

Ascites

4.3

26.6

160

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

26.3

121

420

WX882

NOMESCO Finland

High dependency care

3.4

26.2

286

M79.7

ICD-10 Finland

Fibromyalgia

3.2

26.2

108

352

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.4

26.1

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

73.5

25.8

G90.8

ICD-10 Finland

Other disorders of autonomic nervous system

136.4

25.6

R51

ICD-10 Finland

Headache

2.4

25.6

182

788

N06AX22

ATC

agomelatine; oral

3.4

25.4

272

E66.8

ICD-10 Finland

Other obesity

2.4

25.3

173

736

H02AB06

ATC

prednisolone; systemic

1.6

25.2

1113

8484

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

7.0

25.0

G47.3

ICD-10 Finland

Sleep apnoea

1.7

24.7

542

3480

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

5.4

24.7

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.8

24.2

Z2446

NOMESCO Finland

Social worker

2.3

24.1

195

892

YJA10

NOMESCO Finland

Excision of liver from cadaver donor

+∞

24.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.6

23.6

216

A04

ICPC

Weakness/tiredness general

1.8

23.6

432

2633

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

23.6

525

3381

N06BA07

ATC

modafinil; oral

9.4

23.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

23.4

257

1327

A02BC02

ATC

pantoprazole; systemic

1.5

23.3

1574

13063

H47.3

ICD-10 Finland

Other disorders of optic disc

9.7

23.2

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

23.2

219

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

23.1

182

N05AH03

ATC

olanzapine; systemic

2.3

23.1

189

869

S06.0

ICD-10 Finland

Concussion

2.0

23.0

287

1550

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

22.8

283

1525

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

22.8

158

676

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.4

22.5

133

TK800

NOMESCO Finland

Hemodialysis

3.8

22.5

186

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

22.4

602

4061

N05AX08

ATC

risperidone; systemic

2.1

22.4

221

1095

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

22.4

186

861

SPAT1229

SPAT

Assessment of need for aid

2.3

22.2

166

735

N99

ICPC

Neurological disease other

4.9

22.0

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

21.9

148

625

G91.8

ICD-10 Finland

Other hydrocephalus

+∞

21.9

R4120

NOMESCO Finland

Occupational therapy

2.3

21.7

167

748

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.0

21.7

AAF00

NOMESCO Finland

Ventriculostomy

20.2

21.7

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

21.7

150

641

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

7.0

21.6

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

116.0

21.6

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

21.6

195

934

R4190

NOMESCO Finland

Nutritional therapy

2.5

21.4

133

540

N02CD02

ATC

galcanezumab; parenteral

7.6

21.2

AA1AA

NOMESCO Finland

Head X-ray examination

7.3

21.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

21.0

502

3282

A02BC05

ATC

esomeprazole; systemic

1.5

20.9

901

6752

WX704

NOMESCO Finland

Intubation

2.1

20.6

207

1032

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

20.6

328

1914

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.2

20.4

N01

ICPC

Headache

1.8

20.3

348

2075

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

20.3

892

6704

H03AA01

ATC

levothyroxine sodium; systemic

1.6

20.2

507

3353

G44.8

ICD-10 Finland

Other specified headache syndromes

3.7

20.2

172

WX892

NOMESCO Finland

Monitored bed care

2.2

20.0

183

880

G40.10

ICD-10 Finland

Simple partial seizures

6.8

20.0

C07AB02

ATC

metoprolol; systemic

1.7

20.0

399

2485

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

19.9

199

990

N18

ICPC

Paralysis/weakness

4.0

19.9

142

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

19.9

343

G41.2

ICD-10 Finland

Complex partial status epilepticus

36.0

19.8

R51.81

ICD-10 Finland

Facial pain NOS

3.3

19.7

228

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

19.7

312

G45.3

ICD-10 Finland

Amaurosis fugax

29.2

19.6

K72.9

ICD-10 Finland

Hepatic failure, unspecified

7.4

19.5

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.5

19.2

103

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

19.1

176

849

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

19.0

223

1176

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.5

18.9

104

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

18.8

132

568

K72.1

ICD-10 Finland

Chronic hepatic failure

28.0

18.7

ZXY02

NOMESCO Finland

Neuropsychologist

7.1

18.7

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.0

18.6

131

A98

ICPC

Health maint/preventive medicine

0.6

18.6

2176

23149

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

100.8

18.6

N06AA10

ATC

nortriptyline; systemic

3.4

18.5

192

127

Kela drug reimbursment

Transplant complication

4.0

18.5

136

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

18.5

128

547

K90

ICPC

Stroke/cerebrovascular accident

3.3

18.5

212

N04BC05

ATC

pramipexole; oral

2.2

18.4

170

820

J01FF01

ATC

clindamycin; systemic

1.6

18.4

610

4297

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

18.4

613

4324

Z3231

NOMESCO Finland

Registered nurse

1.5

18.3

613

4328

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

18.3

188

946

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.2

18.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

18.1

269

1535

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

18.0

225

1212

R40.2

ICD-10 Finland

Coma, unspecified

6.3

18.0

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

18.0

153

715

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

18.0

206

1078

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

17.9

108

433

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

17.9

428

2789

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

7.0

17.8

N02CD03

ATC

fremanezumab; systemic

4.2

17.7

114

P29

ICPC

Psychological sympt/compl other

1.9

17.7

236

1300

AAF40

NOMESCO Finland

Shunt of cyst of brain to peritoneum

181.2

17.5

XA400

NOMESCO Finland

EEG

6.8

17.4

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

17.4

122

525

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.0

17.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

17.3

118

501

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

17.3

375

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.7

17.2

148

SPAT1255

SPAT

Intravenous administration of medicine

2.1

17.1

157

757

ZXD05

NOMESCO Finland

Urgent procedure

1.5

17.1

715

5281

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.6

17.0

N07AA02

ATC

pyridostigmine; systemic

7.2

17.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

16.7

165

817

N02BF02

ATC

pregabalin; oral

2.1

16.7

161

790

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.9

16.7

263

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

16.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

16.6

251

1437

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.4

16.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

16.6

123

542

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

16.6

285

1696

A01

ICPC

Pain general/multiple sites

1.9

16.6

235

1319

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

16.6

349

2197

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

16.6

103

419

WX900

NOMESCO Finland

Resuscitation

16.4

16.5

AAF15

NOMESCO Finland

Ventriculoatrial shunt

171.1

16.5

R4110

NOMESCO Finland

Physiotherapy

1.5

16.5

606

4350

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.9

16.5

125

SPAT1263

SPAT

Sampling

1.4

16.4

963

7575

G40

ICD-10 Finland

Epilepsy

4.9

16.4

N05AX12

ATC

aripiprazole; systemic

2.3

16.4

131

597

N02CD01

ATC

erenumab; parenteral

4.5

16.4

R52.9

ICD-10 Finland

Pain, unspecified

1.8

16.3

248

1422

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.5

16.3

163

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

16.3

178

915

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.7

16.3

317

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.1

16.1

105

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.3

16.1

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.3

16.1

P76

ICPC

Depressive disorder

1.9

16.1

201

1083

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

16.0

237

1349

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

15.9

193

1030

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.6

15.9

147

N02BF01

ATC

gabapentin; oral

1.8

15.8

231

1308

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

15.8

586

4210

SPAT1240

SPAT

Therapeutic discussion

1.7

15.8

286

1727

ZX120

NOMESCO Finland

Intravenous

1.9

15.8

211

1162

AAF10

NOMESCO Finland

Lumboperitoneal shunt

+∞

15.6

G93.9

ICD-10 Finland

Disorder of brain, unspecified

+∞

15.6

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

15.6

230

Q04.6

ICD-10 Finland

Congenital cerebral cysts

85.6

15.6

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

15.6

175

909

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

15.5

586

4224

I47.2

ICD-10 Finland

Ventricular tachycardia

3.3

15.5

179

R52.2

ICD-10 Finland

Other chronic pain

2.5

15.4

410

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

12.4

15.3

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

15.3

316

1978

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

15.2

106

455

N06AA09

ATC

amitriptyline; systemic

1.9

15.2

184

981

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.1

15.1

202

XF404

NOMESCO Finland

Ambulatory ECG

2.0

15.1

181

961

SPAT1216

SPAT

Assessment of functional ability

1.7

15.0

298

1845

P03

ICPC

Feeling depressed

1.7

14.9

294

1817

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.8

371

2438

H47.2

ICD-10 Finland

Optic atrophy

11.4

14.8

K91

ICPC

Cerebrovascular disease

4.8

14.7

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

14.6

162

837

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

+∞

14.6

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

14.5

425

2896

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

14.5

200

1113

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

14.5

277

1698

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.7

14.4

123

G50.1

ICD-10 Finland

Atypical facial pain

3.4

14.4

147

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

14.4

965

7723

M54.2

ICD-10 Finland

Cervicalgia

1.9

14.3

198

1102

L04AD02

ATC

tacrolimus; systemic

4.0

14.3

101

Z3226

NOMESCO Finland

Physiotherapist

1.6

14.3

388

2596

A02BC01

ATC

omeprazole; systemic

1.5

14.3

569

4137

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

14.2

189

L04AA06

ATC

mycophenolic acid; systemic

3.2

14.1

179

N06AB03

ATC

fluoxetine; oral

1.7

14.1

278

1716

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

14.1

275

1694

R13

ICD-10 Finland

Dysphagia

2.0

14.1

161

842

A02BA02

ATC

ranitidine; systemic

1.6

14.0

368

2444

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

14.0

438

3028

C09CA06

ATC

candesartan; oral

1.5

13.9

506

3608

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

13.9

227

1329

SPAT1260

SPAT

Consultation of another employee

1.6

13.9

377

2521

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.8

407

2773

G41.0

ICD-10 Finland

Grand mal status epilepticus

20.1

13.8

N89

ICPC

Migraine

2.1

13.8

125

600

ZY010

NOMESCO Finland

Hospital outpatient

2.0

13.8

152

785

N05CD08

ATC

midazolam; nasal, systemic

3.0

13.7

198

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

13.7

168

899

G44.0

ICD-10 Finland

Cluster headache syndrome

3.8

13.7

109

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

13.7

463

3252

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

13.7

141

710

W19

ICD-10 Finland

Unspecified fall

1.8

13.6

223

1307

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.0

13.6

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

13.6

497

3547

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.5

13.6

138

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

13.6

403

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

13.6

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

13.5

192

1078

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

13.5

179

983

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

13.4

684

5204

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

13.3

133

662

J01MA02

ATC

ciprofloxacin; systemic

1.4

13.3

811

6365

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

13.3

165

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

13.3

229

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

4.1

13.3

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.1

13.2

130

643

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

13.2

117

556

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

9.7

13.2

A04AA01

ATC

ondansetron; systemic, rectal

1.9

13.2

180

998

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.0

13.2

N05AD01

ATC

haloperidol; systemic

2.6

13.2

299

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

13.2

203

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

13.1

319

2077

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

13.1

312

R03AC02

ATC

salbutamol; inhalant

1.4

13.0

1287

10911

N06AB05

ATC

paroxetine; oral

2.0

13.0

139

709

K92.0

ICD-10 Finland

Haematemesis

2.9

13.0

221

N02AA05

ATC

oxycodone; systemic

1.6

13.0

354

2369

G43.8

ICD-10 Finland

Other migraine

3.1

13.0

178

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.4

13.0

380

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

5.2

13.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

12.9

210

1228

E23.06

ICD-10 Finland

Empty sella

19.1

12.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

12.9

109

509

N05CD07

ATC

temazepam; oral

1.8

12.8

216

1276

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

12.7

212

1249

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

9.7

12.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

12.7

194

1115

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.8

12.6

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.1

12.6

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

12.5

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.6

12.5

283

Z94.4

ICD-10 Finland

Liver transplant status

9.3

12.5

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.8

12.4

N02CC03

ATC

zolmitriptan; nasal, oral

2.0

12.4

142

742

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

13.2

12.4

JJC00

NOMESCO Finland

Allogenic transplantation of liver

13.2

12.4

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

12.3

175

982

UJF32

NOMESCO Finland

Coloscopy

1.5

12.3

506

3688

C09AA05

ATC

ramipril; oral

1.5

12.2

448

3194

K92.1

ICD-10 Finland

Melaena

2.1

12.2

114

554

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

12.1

241

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

12.1

279

1793

C07AG02

ATC

carvedilol; oral

2.1

12.1

110

529

J45.8

ICD-10 Finland

Mixed asthma

2.5

12.1

288

SPAT1153

SPAT

Removal of sutures

1.4

12.0

615

4667

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.3

12.0

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

12.0

102

478

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

11.9

401

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

11.9

732

5732

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.2

11.9

101

473

B01AC04

ATC

clopidogrel; oral

1.6

11.8

259

1642

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

11.8

157

863

205

Kela drug reimbursment

Chronic hypertension

1.5

11.8

453

3259

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

11.7

887

7177

T82

ICPC

Obesity

2.1

11.7

113

556

L01AX03

ATC

temozolomide; systemic

4.8

11.7

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

11.6

226

1389

H57.1

ICD-10 Finland

Ocular pain

2.1

11.6

103

490

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

11.6

104

497

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

11.6

632

4844

A05

ICPC

Feeling ill

1.8

11.6

172

979

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.1

11.6

158

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

11.5

722

5664

ZXA10

NOMESCO Finland

Bilateral

1.5

11.5

361

2488

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

11.5

284

1854

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

11.5

139

741

Z08

ICPC

Social welfare problem

3.3

11.5

128

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

11.5

233

1449

G43.2

ICD-10 Finland

Status migrainosus

5.7

11.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

5.0

11.5

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

5.0

11.5

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

11.5

PH4YT

NOMESCO Finland

Dilatation of vein of head or brain

+∞

11.5

T71

ICD-10 Finland

Asphyxiation

+∞

11.5

AAF45

NOMESCO Finland

Fenestration of intracranial cyst

+∞

11.5

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.4

11.4

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

11.4

196

1164

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.7

11.4

231

R03DC03

ATC

montelukast; oral

1.5

11.4

373

2595

N06AG02

ATC

moclobemide; oral

2.2

11.4

422

H02AB04

ATC

methylprednisolone; systemic

1.6

11.4

288

1893

P01

ICPC

Feeling anxious/nervous/tense

1.5

11.3

368

2555

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

11.3

844

6804

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

11.3

215

K07.60

ICD-10 Finland

Snapping jaw

1.9

11.3

138

738

AN1

Coronary angiography

1.7

11.3

191

1130

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

35.2

11.3

N05CF02

ATC

zolpidem; oral

1.5

11.3

363

2517

RD210, ,

NOMESCO Finland

2.9

11.2

188

J01EA01

ATC

trimethoprim; systemic

1.4

11.2

513

3809

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

11.1

127

664

N06AX05

ATC

trazodone; oral

2.5

11.1

264

N04BD01

ATC

selegiline; oral

3.6

11.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

11.1

382

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

11.2

11.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

11.0

271

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

11.0

263

1704

N05AB03

ATC

perphenazine; systemic, rectal

2.3

11.0

383

K76.7

ICD-10 Finland

Hepatorenal syndrome

13.9

11.0

N88

ICPC

Epilepsy

4.7

10.9

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.7

10.9

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

10.9

148

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.4

10.9

291

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

10.8

108

538

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

10.8

121

628

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

10.8

133

M79.1

ICD-10 Finland

Myalgia

1.5

10.8

349

2419

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

10.8

229

1440

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

10.8

421

3032

N30.0

ICD-10 Finland

Acute cystitis

1.5

10.8

368

2581

B02AA02

ATC

tranexamic acid; systemic

1.5

10.8

314

2130

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.9

10.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.5

10.7

104

R03BA05

ATC

fluticasone; inhalant

1.5

10.7

406

2908

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.5

10.7

275

N17

ICPC

Vertigo/dizziness

1.6

10.7

265

1732

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

10.7

204

1249

R02

ICPC

Shortness of breath/dyspnoea

1.6

10.7

280

1855

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

10.7

392

2791

N02CC05

ATC

almotriptan; oral

2.1

10.6

102

501

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

10.6

692

5451

P99

ICPC

Psychological disorders other

2.2

10.6

415

N05BA12

ATC

alprazolam; oral

1.7

10.6

201

1228

D97

ICPC

Liver disease NOS

5.3

10.6

SPAT1310

SPAT

Counselling related to known health issue

1.4

10.6

682

5364

N05AA02

ATC

levomepromazine; systemic

2.1

10.6

442

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

10.5

533

4027

N03AB02

ATC

phenytoin; systemic

4.0

10.5

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.6

10.5

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

10.4

168

G92

ICD-10 Finland

Toxic encephalopathy

+∞

10.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

10.4

284

1897

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.1

10.4

F34.1

ICD-10 Finland

Dysthymia

2.1

10.4

459

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

10.3

220

C01CA24

ATC

epinephrine; parenteral

1.8

10.3

159

916

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

10.3

132

718

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

18.9

10.3

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.2

237

1524

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

10.2

396

2847

JN4AD

NOMESCO Finland

Body CT examination

1.6

10.2

221

1398

SPAT1262

SPAT

Handing over of treatment supplies

1.5

10.2

327

2264

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

10.1

B01AA03

ATC

warfarin; systemic

1.5

10.1

328

2274

J01DA01

ATC

[U] cefalexin

1.3

10.1

1373

12005

R4120, ,

SPAT

3.3

10.1

113

C10AC01

ATC

colestyramine; oral

2.5

10.1

252

OAB43, ,

SPAT

0.7

10.1

540

6924

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.1

849

6946

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

10.0

176

1052

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

11.3

10.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.0

428

3132

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.0

10.0

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.5

10.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

10.0

104

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

10.0

328

R52.1

ICD-10 Finland

Chronic intractable pain

4.1

10.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

9.9

430

3155

F61.0

ICD-10 Finland

Mixed personality disorders

2.9

9.9

162

M54.1

ICD-10 Finland

Radiculopathy

2.2

9.9

407

E23.00

ICD-10 Finland

Panhypopituitarism

7.6

9.9

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.9

9.9

XKC03

NOMESCO Finland

Water cystometry

2.6

9.8

220

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

9.8

118

629

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

9.8

138

774

R06AE07

ATC

cetirizine; oral

1.3

9.8

990

8303

H93.1

ICD-10 Finland

Tinnitus

1.8

9.8

145

826

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

9.8

203

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

9.7

165

977

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

9.7

186

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

9.7

257

SPAT1252

SPAT

Overall medication plan or its review

1.9

9.7

127

696

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.0

9.6

143

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

9.6

283

SPAT1050

SPAT

Extensive neurological examination

2.8

9.6

165

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.2

9.6

117

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.5

9.5

R4130

NOMESCO Finland

Speech therapy

2.5

9.5

247

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

9.5

260

1736

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

9.5

125

686

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

9.5

242

1591

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.8

9.5

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

9.5

496

G43

ICD-10 Finland

Migraine

1.8

9.5

154

902

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

9.4

298

ABB20

NOMESCO Finland

Drainage of intra- or extramedullary cyst of spinal canal

100.4

9.4

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

30.1

9.4

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

9.4

122

667

G91.3

ICD-10 Finland

Post-traumatic hydrocephalus, unspecified

+∞

9.4

G93

ICD-10 Finland

Other disorders of brain

+∞

9.4

GBB03

NOMESCO Finland

Percutaneous tracheostomy

+∞

9.4

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.5

9.3

E66.0

ICD-10 Finland

Obesity due to excess calories

4.0

9.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

9.3

261

1754

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

9.3

398

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.1

9.2

125

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

9.2

119

649

J01DB01

ATC

cefalexin; oral

1.4

9.2

1952

18037

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

9.2

409

3012

A86

ICD-10 Finland

Unspecified viral encephalitis

7.7

9.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.6

9.1

193

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.6

9.1

205

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

9.1

166

1005

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

9.1

113

610

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

11.5

9.1

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

9.0

153

906

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

9.0

379

2762

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

9.0

172

1052

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

36.8

9.0

D35.4

ICD-10 Finland

Benign neoplasm: Pineal gland

36.8

9.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

9.0

206

E87.6

ICD-10 Finland

Hypokalaemia

2.2

8.9

318

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

7.5

8.9

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

8.9

195

N02CC04

ATC

rizatriptan; oral

1.8

8.9

136

782

ZXC95

NOMESCO Finland

Use of surgical navigator

3.3

8.9

102

A10AB05

ATC

insulin aspart; parenteral

1.7

8.9

164

995

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.9

8.9

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.9

8.9

R06.4

ICD-10 Finland

Hyperventilation

2.9

8.9

139

L29

ICPC

Musculoskeletal sympt/complt other

1.6

8.8

187

1176

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.8

8.8

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.7

8.8

N06AX03

ATC

mianserin; oral

2.0

8.8

468

N02CC06

ATC

eletriptan; oral

2.0

8.8

475

D01

ICPC

Abdominal pain/cramps general

1.5

8.7

290

2019

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

8.7

197

R33

ICD-10 Finland

Retention of urine

1.7

8.7

154

923

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

8.7

243

1632

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.7

493

3785

H02AA02

ATC

fludrocortisone; oral

4.3

8.7

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

8.6

278

3914

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

8.6

116

642

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

8.6

K30

ICD-10 Finland

Functional dyspepsia

1.5

8.6

239

1602

A29

ICPC

General symptom/complaint other

1.5

8.6

276

1908

R5110, ,

SPAT

1.7

8.6

157

951

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.5

8.6

205

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

6.9

8.5

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.3

8.5

273

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.5

8.5

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

8.5

267

R21

ICPC

Throat symptom/complaint

1.4

8.5

542

4235

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.2

8.5

105

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

8.5

124

704

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.4

8.5

AAK00

NOMESCO Finland

Cranioplasty

20.1

8.5

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

8.5

319

M01AE02

ATC

naproxen; oral, rectal

1.3

8.4

1284

11284

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

8.4

164

1011

M54.5

ICD-10 Finland

Low back pain

1.3

8.4

801

6633

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.3

8.3

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.3

8.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

8.3

321

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

8.3

321

G90.0

ICD-10 Finland

Idiopathic peripheral autonomic neuropathy

+∞

8.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

8.3

291

2047

UKC02

NOMESCO Finland

Cystoscopy

1.5

8.3

287

2014

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

8.3

249

1697

WX402

NOMESCO Finland

General anaesthesia

1.4

8.2

478

3679

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

8.2

162

1001

N06BA04

ATC

methylphenidate; oral

1.8

8.2

116

653

N02CD06

ATC

rimegepant; oral

3.7

8.2

T07

ICPC

Weight gain

2.4

8.2

216

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

8.1

441

3356

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.1

8.1

108

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

8.1

108

596

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

8.1

103

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

8.1

489

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

8.1

475

AA1BG, ,

SPAT

2.4

8.1

211

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

8.1

199

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

6.8

8.1

N05BE01

ATC

buspirone; oral

2.2

8.1

306

J01MA12

ATC

levofloxacin; systemic

1.4

8.0

351

2575

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

8.0

117

665

R41.3

ICD-10 Finland

Other amnesia

2.4

8.0

231

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

8.0

354

C09AA02

ATC

enalapril; systemic

1.4

8.0

328

2381

M03AX01

ATC

botulinum toxin; parenteral

2.6

8.0

165

UDC00

NOMESCO Finland

Ear microscopy

1.7

7.9

152

932

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.4

7.9

219

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.1

7.9

355

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.0

7.9

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

7.9

160

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

13.1

7.9

N05AF03

ATC

chlorprothixene; systemic

2.3

7.9

264

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

7.8

100

545

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

7.8

118

677

SPAT1312

SPAT

General health counselling

1.3

7.8

684

5587

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

7.8

215

1439

D11

ICPC

Diarrhoea

1.5

7.8

284

2014

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.8

7.8

H02AB07

ATC

prednisone; oral

1.5

7.8

253

1754

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.8

625

5045

H52.5

ICD-10 Finland

Disorders of accommodation

9.4

7.8

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

7.8

106

590

I50.0

ICD-10 Finland

Congestive heart failure

1.7

7.7

123

718

UJD02

NOMESCO Finland

Gastroscopy

1.9

7.7

491

N05AN01

ATC

lithium; oral

2.2

7.7

273

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.4

7.7

SPAT1254

SPAT

Administration of medicine

1.4

7.6

299

2149

A10AE04

ATC

insulin glargine; parenteral

1.6

7.6

193

1267

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

7.6

123

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

7.6

232

1586

ZXD00

NOMESCO Finland

Emergency procedure

2.1

7.6

360

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

7.6

236

UDM02

NOMESCO Finland

Sinoscopy

2.4

7.6

205

PA1AD

NOMESCO Finland

CT of aortic arch and branches

18.4

7.6

Z43.0

ICD-10 Finland

Attention to tracheostomy

18.4

7.6

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

7.6

479

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

7.6

522

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

25.1

7.6

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

25.1

7.6

AAK80

NOMESCO Finland

Partial excision of skull cap

25.1

7.6

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

7.6

124

729

N05AB04

ATC

prochlorperazine; systemic, rectal

2.7

7.6

152

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

7.6

243

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.5

7.5

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.1

7.5

308

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.1

7.5

R00.2

ICD-10 Finland

Palpitations

1.6

7.5

174

1119

AS7

Arrhythmia pacemaker insertion VVI (R) S

10.0

7.5

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.8

7.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

7.5

182

1184

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.5

923

7869

H81.4

ICD-10 Finland

Vertigo of central origin

4.2

7.5

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

7.5

316

A02BC03

ATC

lansoprazole; oral

1.3

7.4

521

4122

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

7.4

189

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

80.3

7.4

G90.2

ICD-10 Finland

Horner syndrome

80.3

7.4

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

80.3

7.4

X58

ICD-10 Finland

Exposure to other specified factors

1.4

7.4

327

2402

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

7.4

133

802

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

7.4

483

3782

R60.0

ICD-10 Finland

Localized oedema

1.5

7.4

230

1581

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

7.4

113

652

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

3.8

7.4

SPAT1097

SPAT

Recording of ECG

1.5

7.3

249

1741

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

7.3

150

936

XG466

NOMESCO Finland

Sleep oxymetry

2.2

7.3

285

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

7.3

449

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

7.3

240

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

7.3

274

1953

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

7.3

279

OAA80, ,

SPAT

0.6

7.3

103

1753

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

7.3

AAA10

NOMESCO Finland

Biopsy through craniotomy

+∞

7.3

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

7.3

398

3030

J02AC01

ATC

fluconazole; systemic

1.3

7.3

811

6822

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

9.4

7.3

A10AC01

ATC

insulin (human); parenteral

1.6

7.3

156

986

T91

ICPC

Vitamin/nutritional deficiency

3.8

7.2

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.4

7.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.2

268

1907

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

7.2

510

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.8

7.2

122

L99

ICPC

Musculoskeletal disease other

2.3

7.1

211

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

7.1

489

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

7.1

145

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.8

7.1

117

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

12.0

7.1

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

7.1

125

751

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.1

582

4706

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

7.0

172

1121

XQ800

NOMESCO Finland

Prick test

1.6

7.0

164

1057

OAA67, ,

SPAT

0.7

7.0

233

3271

IHZ05, ,

SPAT

1.7

7.0

119

707

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.8

7.0

118

M79.6

ICD-10 Finland

Pain in limb

1.3

7.0

925

7934

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.3

7.0

226

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.4

7.0

201

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

7.0

522

F10.24

ICD-10 Finland

Alcohol depence active use

2.6

7.0

141

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

7.0

109

633

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.5

6.9

165

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.9

228

1585

Z94.0

ICD-10 Finland

Kidney transplant status

3.0

6.9

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.7

6.9

2152

FHL

Extraction, big brain

13.8

6.9

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

6.9

294

2147

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

6.9

118

704

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

6.9

107

621

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

6.9

178

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

6.8

166

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

6.8

228

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

8.3

6.8

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

6.8

390

D33.07

ICD-10 Finland

Colloid coast in cerebral ventricle

11.0

6.8

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

11.0

6.8

K76.9

ICD-10 Finland

Liver disease, unspecified

2.9

6.8

109

A46

ICD-10 Finland

Erysipelas

1.4

6.8

267

1921

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

9.3

6.8

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

9.3

6.8

A10BA02

ATC

metformin; oral

1.3

6.8

515

4116

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.0

6.8

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

6.8

469

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

6.8

569

4611

SAA04

NOMESCO Finland

Special examination of mouth

1.7

6.8

118

707

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.3

6.7

F83

ICD-10 Finland

Mixed specific developmental disorders

3.6

6.7

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

6.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.7

125

762

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

6.7

406

Z31.5

ICD-10 Finland

Genetic counselling

1.7

6.7

126

770

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

382

425

10.40

320.01

1.6

1.4

256.13

1622.76

e6/l

1.08

316

331

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

378

417

10.47

318.60

1.6

1.3

9.41

32.38

e6/l

0.94

295

309

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

433

486

10.53

307.65

1.5

1.3

441.16

529.98

mg/l

1.39

422

460

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

404

443

10.66

307.65

1.5

1.3

3.70

3.68

mmol/l

0.08

386

421

(3044290) Cell count panel - Cerebral spinal fluid

337

404

9.46

265.48

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

290

426

7.56

191.23

6.7

2.9

42.30

33.96

umol/l

4.06

269

391

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1166

5732

2.91

148.13

2.9

2.1

267.11

241.95

u/l

0.22

1134

5439

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

155

143

11.48

146.18

1.3

1.2

1.77

2.07

mmol/l

2.62

146

132

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

165

184

9.52

135.89

1.2

1.1

46.59

40.45

mg/l

0.27

145

149

(3036481) Cortisol [Moles/volume] in Serum or Plasma

604

2132

3.40

135.49

2.4

2.1

394.01

378.23

nmol/l

0.57

573

1989

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

160

180

9.42

130.85

1.2

1.1

299.59

254.97

mg/l

0.31

143

154

(3016018) Differential panel - Cerebral spinal fluid

170

214

8.44

127.16

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

148

161

9.70

124.07

1.8

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

166

232

7.59

113.45

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

134

148

9.50

110.96

1.3

1.2

0.55

0.65

ratio

0.90

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

143

174

8.65

109.80

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

153

204

7.92

108.88

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

155

211

7.76

108.35

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

741

3357

2.70

103.16

4.6

3.7

0.82

mmol/l

0.29

700

3187

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

119

135

9.20

96.45

1.2

1.0

1.14

1.06

u/l

0.34

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

100

11.66

96.26

1.6

1.1

57.22

74.77

—

(3020779) Urea [Moles/volume] in Serum or Plasma

485

1820

3.06

95.34

9.3

8.5

8.69

9.43

mmol/l

1.55

463

1759

(3005719) IgG [Mass/volume] in Serum or Plasma

462

1692

3.12

94.71

2.5

2.9

10.80

10.76

g/l

0.06

424

1575

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

418

1467

3.21

91.96

2.6

2.4

23.85

21.22

au/ml

0.17

179

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

390

1353

3.22

87.22

1.4

1.3

40.70

54.19

au/ml

0.48

(3018677) aPTT in Platelet poor plasma by Coagulation assay

629

2877

2.58

83.62

2.6

2.3

29.61

29.70

0.12

611

2787

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1500

9980

2.23

82.12

11.0

7.2

1.20

1.21

mmol/l

3.73

1310

8631

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1376

8912

2.19

79.72

11.4

6.8

1.20

1.21

mmol/l

3.09

1309

8282

(3003458) Phosphate [Moles/volume] in Serum or Plasma

587

2665

2.56

78.73

8.1

6.7

1.07

1.05

mmol/l

0.83

563

2484

(3032080) INR in Blood by Coagulation assay

1358

8806

2.16

77.73

15.7

13.9

1.22

1.23

inr

0.44

1179

7320

(3013826) Glucose [Moles/volume] in Serum or Plasma

1694

12218

2.16

70.51

8.8

5.1

6.69

6.60

mmol/l

0.84

1623

11433

(3019977) pH of Arterial blood

494

2199

2.55

68.12

12.1

8.9

7.40

7.42

1.42

299

1211

(3003396) Base excess in Arterial blood by calculation

491

2184

2.55

67.78

11.9

8.8

0.84

0.87

mmol/l

0.05

395

1779

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

492

2204

2.53

66.83

12.2

8.8

5.01

5.09

kpa

1.09

475

2118

(3027801) Oxygen [Partial pressure] in Arterial blood

492

2204

2.53

66.83

12.2

8.8

13.28

12.35

kpa

2.71

474

2120

(3024561) Albumin [Mass/volume] in Serum or Plasma

1337

8939

2.05

66.80

7.5

5.1

35.31

36.09

g/l

4.78

1264

8423

(3016502) Oxygen saturation in Arterial blood

446

1959

2.55

62.85

12.4

9.3

96.21

95.48

1.55

433

1899

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1040

6539

2.00

59.76

3.9

2.6

60.32

58.49

u/l

0.25

985

6097

(3008152) Bicarbonate [Moles/volume] in Arterial blood

302

1121

2.92

58.96

13.9

7.3

23.99

24.32

mmol/l

0.66

291

1070

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1123

7305

1.96

57.99

4.3

3.4

115.20

74.34

ng/l

0.30

747

4640

(3021447) Carbon dioxide [Partial pressure] in Venous blood

449

2068

2.42

56.67

5.8

4.3

5.68

5.84

kpa

2.80

432

2011

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.53

56.42

1.3

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

410

1816

2.50

56.33

13.7

9.8

122.21

122.61

g/l

0.13

400

1773

(3012544) pH of Venous blood

447

2069

2.41

55.73

6.0

4.4

7.37

7.38

2.56

297

1197

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

7.59

55.24

1.2

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1492

10795

1.93

54.83

9.3

6.3

12.37

11.72

umol/l

0.50

1436

10287

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

7.41

54.77

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

434

2010

2.40

53.90

5.9

4.4

1.40

1.73

mmol/l

0.97

345

1721

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

507

3.59

49.79

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

586

3186

2.09

48.66

1.6

1.4

404.67

492.56

titre

0.72

120

669

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

244

900

2.89

47.87

1.8

2.0

40.29

39.73

u/l

0.16

219

822

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

175

532

3.46

47.59

1.5

1.4

281.15

236.43

u/ml

1.12

118

330

(3023368) Bacteria identified in Blood by Culture

872

5530

1.88

45.88

5.2

4.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

160

473

3.54

45.40

1.6

1.5

117.48

156.27

au/ml

2.11

130

(1616796) Gas panel - Central venous blood

159

476

3.50

44.25

3.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

565

3142

2.03

43.54

1.8

1.7

1218.33

1155.54

nmol/l

0.86

460

2407

(3009466) Valproate [Moles/volume] in Serum or Plasma

120

308

4.04

41.73

5.2

6.2

378.72

373.21

umol/l

0.16

105

276

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

12.30

40.20

1.1

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

308

1397

2.37

39.39

6.3

4.1

5.13

kpa

0.04

297

1349

(3018418) pH of Serum or Plasma

891

5920

1.78

38.77

5.4

4.1

7.40

0.12

686

4183

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

135

5.54

37.77

1.1

0.25

5.42

nmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

665

4092

1.85

37.05

1.8

1.7

453.94

27679506.57

pmol/l

3.29

578

3490

(3004789) Transferrin [Mass/volume] in Serum or Plasma

556

3232

1.92

36.98

3.4

2.6

2.34

g/l

0.02

517

2986

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.05

36.92

1.7

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

211

830

2.68

36.40

4.7

3.5

23.79

25.21

mmol/l

5.58

204

795

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1040

7317

1.71

36.32

5.1

3.2

48.72

31.96

u/l

0.97

993

6942

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

377

1923

2.13

36.09

3.8

2.5

0.20

0.21

g/l

3.16

353

1797

(3009343) pH of Capillary blood

295

1363

2.32

36.03

6.4

4.2

7.40

7.41

2.41

252

1160

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

273

1221

2.38

35.91

6.4

4.1

1.71

1.68

mmol/l

0.04

182

905

(3028026) IgM [Mass/volume] in Serum or Plasma

291

1339

2.33

35.87

1.9

1.24

1.40

g/l

1.06

272

1243

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

515

2958

1.93

35.33

3.5

2.7

24.25

23.54

0.52

478

2755

(3022948) Iron [Moles/volume] in Serum or Plasma

584

3497

1.87

35.24

3.5

2.6

13.67

13.70

umol/l

0.04

546

3265

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.25

35.21

1.2

1.1

1777.83

291.50

ng/l

0.39

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

564

3355

1.88

34.68

2.3

1.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

184

692

2.79

34.60

3.7

3.1

23.78

24.70

mmol/l

1.83

178

683

(3015377) Calcium [Moles/volume] in Serum or Plasma

990

6946

1.70

34.42

3.5

3.3

2.33

2.35

mmol/l

2.97

909

6369

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

747

4860

1.76

34.06

2.2

1.8

1.36

1.12

mg/l

0.84

558

3704

(3014111) Lactate [Moles/volume] in Serum or Plasma

357

1827

2.11

33.75

10.5

8.7

1.55

1.32

mmol/l

2.69

343

1792

(3048929) Epstein Barr virus Ab [Presence] in Serum

225

949

2.50

33.59

1.4

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

344

1759

2.11

32.53

5.8

3.7

4.79

4.61

kpa

0.81

328

1712

(3026008) Bacteria identified in Urine by Culture

876

6024

1.69

32.34

3.8

2.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

180

697

2.70

31.97

2.5

2.4

548.68

449.99

ug/l

0.24

169

658

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

298

1455

2.19

31.69

12.1

9.5

23.76

24.76

mmol/l

4.90

292

1448

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

292

1415

2.20

31.64

3.6

3.5

4.52

4.59

pmol/l

0.67

261

1278

(3006315) Basophils [#/volume] in Blood

1435

11242

1.64

31.35

7.8

6.4

0.04

e9/l

0.72

1302

9707

(3001604) Monocytes [#/volume] in Blood

1432

11228

1.63

31.05

7.7

6.4

0.56

0.57

e9/l

0.67

1301

9694

(3004119) Hemoglobin [Mass/volume] in Venous blood

259

1211

2.27

30.58

4.7

3.6

130.18

129.86

g/l

0.07

245

1177

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

335

1748

2.06

29.87

1.4

1.2

82.62

146.40

u/ml

3.56

133

675

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

412

2318

1.93

29.61

3.7

4.4

255.79

248.94

u/l

0.21

385

2212

(3013115) Eosinophils [#/volume] in Blood

1461

11589

1.61

29.55

8.0

6.7

0.18

0.19

e9/l

0.60

1334

10203

(3019198) Lymphocytes [#/volume] in Blood

1453

11516

1.61

29.44

7.8

6.5

1.85

1.96

e9/l

2.89

1334

10229

(3008295) Osmolality of Serum or Plasma

239

3.82

29.07

1.4

1.5

284.30

281.93

mosm/kgh2o

0.44

178

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.80

28.93

1.2

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

302

1540

2.09

28.59

2.3

2.7

66.14

66.89

g/l

0.92

283

1434

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.65

28.47

1.2

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1877

15919

1.69

28.36

11.3

7.8

81.37

77.93

u/l

2.21

1809

15166

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

178

731

2.54

28.03

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

285

1432

2.12

28.03

2.7

2.3

13.96

7.51

ug/l

1.67

257

1274

(3033658) Prothrombin time (PT) actual/Normal

764

5225

1.66

27.94

7.3

4.1

88.17

90.17

1.25

743

5120

(3015171) Extractable nuclear Ab [Units/volume] in Serum

204

895

2.39

27.85

1.4

1.2

0.47

1.07

u/ml

0.71

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

826

5776

1.64

27.60

2.9

2.3

2.88

2.74

mg/l

0.87

749

5013

(3020191) Ethanol [Moles/volume] in Serum or Plasma

186

4.12

27.34

1.8

1.6

0.84

1.26

promille

1.60

148

(3047181) Lactate [Moles/volume] in Blood

146

555

2.73

26.85

10.3

6.8

1.55

1.35

mmol/l

0.74

132

475

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

190

824

2.41

26.60

9.7

5.7

1.70

1.62

0.59

176

773

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

209

946

2.32

26.56

6.0

3.9

49.99

48.77

0.27

202

930

(3007853) Bacteria identified in Skin by Aerobe culture

431

2557

1.83

25.98

2.0

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

145

561

2.68

25.76

1.7

2.2

11.61

11.23

mg/l

0.24

139

525

(3012501) Base excess in Blood by calculation

123

439

2.89

25.46

4.7

4.2

2.18

2.46

mmol/l

0.47

278

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1237

9637

1.55

25.45

3.2

2.4

72.05

75.11

nmol/l

3.11

1150

8888

(3010421) pH of Blood

161

660

2.54

25.44

4.5

3.8

7.40

7.41

1.10

155

654

(3013290) Carbon dioxide [Partial pressure] in Blood

123

440

2.89

25.35

4.7

4.2

4.85

5.02

kpa

1.54

117

434

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

164

681

2.51

25.22

1.7

1.8

0.22

0.23

g/l

1.55

158

650

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

168

706

2.48

25.18

1.7

1.8

1.14

1.18

g/l

0.88

162

675

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.21

25.03

1.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

416

2469

1.82

24.97

2.2

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

279

1450

2.04

24.96

1.8

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

763

5337

1.61

24.95

3.5

3.2

1458.30

1395.93

ng/l

0.13

655

4507

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1147

8821

1.55

24.79

2.5

2.0

95.76

95.90

pmol/l

0.03

704

4908

(3027315) Oxygen [Partial pressure] in Blood

122

440

2.86

24.77

4.7

4.2

9.28

8.60

kpa

4.18

116

434

(3013650) Neutrophils [#/volume] in Blood by Automated count

1526

12502

1.55

24.67

10.7

9.5

4.18

4.08

e9/l

0.82

1395

10853

(3036489) Thrombin time

186

826

2.35

24.67

2.6

2.5

21.04

20.90

0.14

164

739

(3013247) Albumin in CSF/Albumin in Serum or Plasma

7.54

24.63

1.0

13.69

6.30

mg/g

0.66

(3007930) Methemoglobin/Hemoglobin.total in Blood

173

745

2.42

24.58

10.5

6.0

1.14

0.88

0.82

161

696

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

223

1074

2.18

24.36

14.8

12.3

16.30

16.10

0.43

212

1032

(3007164) IgA [Mass/volume] in Serum or Plasma

705

4870

1.62

24.12

1.7

1.5

2.46

2.33

g/l

0.76

491

3114

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

571

3750

1.67

23.82

4.7

3.6

1468.84

453.08

ng/l

1.51

386

2678

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

253

1291

2.07

23.76

6.4

4.7

23.63

24.07

mmol/l

1.39

247

1280

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

395

2344

1.81

23.63

2.2

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

789

5629

1.58

23.45

1.9

1.7

19.31

19.87

nmol/l

0.52

707

4883

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

7.08

23.33

1.0

—

(3019069) Monocytes/Leukocytes in Blood

1299

10358

1.52

23.16

8.2

6.7

8.60

8.67

0.43

1245

9769

(3026782) Osmolality of Urine

601

4030

1.64

23.02

3.5

2.8

518.43

543.11

mosm/kgh2o

1.99

539

3525

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.94

22.92

1.1

—

(3039000) Anion gap in Blood by calculation

104

359

2.98

22.86

12.7

8.9

11.69

11.63

mmol/l

0.05

318

(3018572) Chloride [Moles/volume] in Blood

104

360

2.97

22.75

12.7

8.9

105.59

105.39

mmol/l

0.11

319

(3022096) Basophils/Leukocytes in Blood

1293

10327

1.51

22.69

8.2

6.6

0.63

0.67

1.88

1238

9723

(3006504) Eosinophils/Leukocytes in Blood

1292

10335

1.51

22.38

8.2

6.6

2.73

2.80

0.49

1237

9739

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

159

692

2.38

22.06

3.6

3.0

3.21

3.60

g/l

2.67

149

660

(3002582) Erythrocytes [#/volume] in Urine

914

6816

1.53

21.97

4.1

3.3

37.57

91.95

e6/l

2.52

748

5174

(3002079) Sodium [Moles/time] in 24 hour Urine

5.13

21.67

1.5

1.2

137.78

171.85

mmol/24h

2.06

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

470

3000

1.70

21.61

2.0

1.8

1.51

1.44

1.55

420

2653

(3002030) Lymphocytes/Leukocytes in Blood

1321

10674

1.50

21.40

8.3

6.5

27.43

28.40

2.78

1273

10173

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

122

4.42

21.32

1.6

1.5

5.88

7.66

u/l

0.50

105

(3042733) HLA Ab [Presence] in Serum

5.33

20.62

3.7

4.4

—

(3018010) Neutrophils/Leukocytes in Blood

1293

10471

1.48

20.27

8.1

6.4

57.74

56.96

1.73

1256

10043

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

138

588

2.42

20.07

4.0

3.7

0.31

0.34

iu/ml

0.41

311

(3009445) Proteinase 3 Ab [Units/volume] in Serum

178

852

2.17

19.70

1.6

1.5

17.64

16.87

iu/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

163

753

2.24

19.68

1.6

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1647

14040

1.49

19.62

6.0

4.3

974.68

1589.29

e6/l

0.42

175

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

225

1187

1.98

19.18

12.9

11.0

23.85

24.29

mmol/l

1.33

219

1165

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

760

5577

1.52

19.10

1.5

1.4

1.46

1.66

u/ml

0.15

230

1508

(3048689) Calprotectin [Mass/mass] in Stool

471

3101

1.64

18.98

2.3

2.7

123.53

117.03

ug/g

0.11

359

2494

(3000850) Epithelial cells [#/volume] in Urine

659

4700

1.54

18.87

3.3

2.6

5.97

6.29

e6/l

0.27

610

4266

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

287

2.99

18.84

1.4

1.3

0.11

0.42

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

666

2.28

18.60

1.4

1.1

3.96

4.26

0.20

103

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

234

3.18

18.26

1.4

1.3

0.16

0.25

nmol/l

0.57

180

(3044007) Cell count panel - Peritoneal fluid

5.64

18.21

4.0

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.06

18.09

3.7

2.3

265.69

975.44

e6/l

2.59

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

100

4.46

18.01

2.8

2.6

59.37

46.68

umol/l

1.70

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

129

561

2.37

17.94

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

477

2.48

17.74

7.2

6.2

1636.89

679.98

iu/ml

0.49

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

146

675

2.23

17.60

3.0

2.9

172.32

179.84

0.50

139

649

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

342

2116

1.71

17.37

7.8

6.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

255

1453

1.84

17.17

5.1

4.3

89.63

87.89

ng/l

0.10

227

1294

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1782

15611

1.47

17.10

5.5

4.1

11.16

10.88

mm/h

0.37

1695

14649

(4062490) Immunoglobulin typing, IgG

214

3.19

16.88

1.9

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

386

2486

1.65

16.82

5.2

2.8

11.29

7.75

umol/l

1.16

327

2175

(3009214) Lutropin [Units/volume] in Serum or Plasma

177

901

2.04

16.65

1.6

1.4

10.74

8.94

u/l

0.75

146

719

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.92

16.63

1.1

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

153

3.58

16.41

1.8

2.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.19

15.93

1.5

1.4

17.68

26.65

g/l

1.25

(3029937) Albumin [Presence] in Urine by Test strip

818

6274

1.45

15.84

5.0

3.7

0.00

estimate

0.17

309

2281

(3037467) Urinalysis macro (dipstick) panel - Urine

1692

14771

1.44

15.77

5.8

4.3

—

3.42

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

376

2.56

15.68

1.7

1.5

346.78

364.41

mu/l

0.25

307

(3017143) Hepatitis C virus Ab [Presence] in Serum

461

3148

1.57

15.68

1.8

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

136

641

2.19

15.65

1.3

71.54

91.19

titre

0.51

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

5.13

15.52

4.0

1.8

2048.63

28387.88

e6/l

0.54

(3042936) Bacteria identified in Isolate by Culture

437

2958

1.58

15.42

2.5

2.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

218

3.03

15.11

1.8

1.3

2.93

g/l

0.00

163

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

4.24

15.05

1.0

1122.22

317.20

ng/l

0.49

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1352

11415

1.39

14.81

4.7

3.2

109.10

108.56

ug/l

0.04

1283

10794

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

388

2.48

14.70

1.4

23.38

21.33

u/l

0.22

328

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

4.05

14.52

2.0

2.9

60.71

138.22

umol/l

1.65

(3019150) Specific gravity of Urine by Refractometry

676

5070

1.45

14.50

4.9

3.6

1.02

1.62

kg/l

0.80

478

3328

(3027135) IgG subclass 1 [Mass/volume] in Serum

218

2.99

14.50

1.8

1.3

6.44

6.73

g/l

0.23

164

(3024139) IgG subclass 3 [Mass/volume] in Serum

218

2.99

14.50

1.8

1.3

0.39

g/l

0.01

161

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

155

791

2.02

14.49

2.8

2.0

2.55

1.82

ug/l

0.32

139

702

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

240

2.88

14.46

1.4

1.3

—

nmol/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

193

1065

1.88

14.35

2.1

1.7

0.30

mg/l

0.03

506

(3023420) DNA double strand Ab [Units/volume] in Serum

177

950

1.93

14.32

1.9

4.27

7.24

iu/ml

1.39

219

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

187

1023

1.89

14.28

5.3

3.4

0.63

0.61

0.28

187

1018

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

4.13

14.19

1.0

32.27

42.00

ng/l

0.78

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

4.13

14.19

1.0

783.26

714.05

ng/l

0.31

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1218

10151

1.38

14.18

3.4

2.8

—

estimate

—

(3015736) pH of Urine

1127

9275

1.39

14.16

4.2

3.2

6.33

6.22

3.26

663

5268

(3018095) Leukocytes [#/volume] in Urine

997

8051

1.39

13.99

5.1

3.8

66.19

91.97

e6/l

0.79

768

5514

(3000570) Elastase.pancreatic [Mass/mass] in Stool

124

590

2.16

13.96

1.5

1.4

318.66

297.09

ug/g

0.46

324

(3030467) Casts [#/volume] in Urine by Automated count

766

5915

1.42

13.92

3.9

3.1

0.39

0.42

e6/l

0.11

606

4304

(3044640) Blood type and Crossmatch panel - Blood

886

7022

1.40

13.85

3.0

2.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

156

3.32

13.83

1.5

1.2

4.31

6.02

umol/l

2.82

137

(3003181) Sodium [Moles/volume] in Urine

315

2.59

13.81

2.3

1.4

76.00

66.50

mmol/l

0.73

258

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

140

701

2.06

13.79

7.3

5.1

1.51

1.45

mg/l

0.34

131

642

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.62

13.76

3.3

2.9

0.60

0.62

mmol/l

0.65

(3035350) Ketones [Presence] in Urine by Test strip

1361

11585

1.38

13.74

4.9

3.6

0.02

5.98

estimate

2.53

333

2465

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

192

1073

1.85

13.72

1.6

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

352

2.49

13.71

1.2

445.71

361.67

titre

—

(3027945) Reticulocytes/Erythrocytes in Blood

351

2317

1.60

13.68

2.9

2.8

1.87

1.76

0.87

302

2101

(3022313) Gas panel - Capillary blood

178

972

1.89

13.67

7.9

4.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

353

2.49

13.63

1.3

2.00

5.05

u/ml

2.24

133

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

254

1545

1.72

13.62

5.1

3.7

1.22

mmol/l

0.72

229

1316

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

244

1471

1.73

13.51

2.7

2.4

4252.83

6434.15

u/l

0.67

612

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

195

3.02

13.46

1.1

276.83

290.12

mg/l

0.71

178

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

117

556

2.16

13.22

2.2

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

530

3856

1.47

13.13

2.8

2.43

2.44

mmol/l

0.58

463

3438

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

229

1368

1.74

13.09

3.4

2.9

179.51

200.12

ng/l

0.36

204

1246

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.80

13.07

1.6

1.4

10.30

13.61

g/l

0.92

(3021601) Nitrite [Presence] in Urine by Test strip

1341

11446

1.36

12.99

4.8

3.5

0.00

estimate

0.80

329

2447

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

325

2.51

12.97

2.4

2.5

28.48

39.93

iu/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

475

2.24

12.97

2.6

2.4

132.92

130.35

g/l

0.49

391

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.24

12.96

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1059

8718

1.37

12.88

4.8

3.4

0.05

0.02

estimate

0.44

286

2048

(3009261) Glucose [Presence] in Urine by Test strip

1356

11615

1.36

12.73

4.9

3.6

0.01

0.14

estimate

0.47

317

2339

(3006653) Thiamine [Moles/volume] in Blood

115

3.61

12.70

1.2

1.3

127.76

140.43

nmol/l

1.07

115

(46235355) HIV 1 and 2 tests - Meaningful Use set

744

5815

1.40

12.31

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

340

2.43

12.26

1.1

1.56

1.49

g/l

0.74

312

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.95

12.15

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

3.19

12.07

1.2

—

(3037121) Protein [Mass/volume] in Urine

140

738

1.95

11.96

3.2

3.7

392.73

320.76

mg/l

0.49

330

(3024980) IgG subclass 4 [Mass/volume] in Serum

369

2.35

11.95

1.8

1.7

0.72

0.75

g/l

0.11

297

(40760892) CBC W Ordered Manual Differential panel - Blood

685

5304

1.40

11.91

5.4

4.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

119

593

2.06

11.91

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

116

3.49

11.81

1.7

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

271

1741

1.62

11.75

2.6

2.7

73.16

70.52

e9/l

0.45

205

1272

(3028707) Methadone [Presence] in Urine by Screen method

118

593

2.04

11.55

2.4

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

2.73

11.49

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

240

1507

1.65

11.39

1.7

1.4

18.89

22.14

iu/l

1.04

209

1268

(3030981) Hyaline casts [#/volume] in Urine by Automated count

252

1605

1.63

11.31

3.1

2.5

0.39

0.45

e6/l

0.18

241

1524

(3005322) IgE [Units/volume] in Serum or Plasma

254

1622

1.63

11.28

1.4

1.3

329.55

258.48

u/ml

0.24

232

1512

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

216

2.72

11.23

1.6

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

202

1217

1.72

11.20

2.2

2.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

101

3.60

11.18

3.1

2.1

1.61

1.98

umol/l

1.57

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

107

527

2.08

11.07

1.4

1.5

0.30

0.42

nmol/l

1.42

431

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

170

2.92

10.82

1.1

1.6

10.47

12.19

umol/l

1.54

155

(3035715) Granulocytes [#/volume] in Blood

399

2.22

10.79

2.6

3.5

4.01

4.12

e9/l

0.16

399

(3021387) Prolactin [Units/volume] in Serum or Plasma

196

1184

1.71

10.76

1.8

1.6

329.73

292.04

mu/l

0.72

178

1074

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

675

5291

1.38

10.71

3.0

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1850

16829

1.37

10.66

5.6

4.3

14.66

14.59

pmol/l

0.57

1755

15624

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

195

2.75

10.52

1.2

66.36

251.56

titre

1.77

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.42

10.26

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

201

1240

1.67

10.21

1.3

1.2

—

(3024932) HLA-DR beta [Type]

3.90

10.12

1.1

—

(40768797) Stomach Pathology biopsy report

396

2852

1.46

10.12

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

206

2.66

10.02

2.3

2.6

1323.52

1263.35

e6/l

0.17

181

(3000963) Hemoglobin [Mass/volume] in Blood

2243

23378

0.65

9.99

36.7

21.9

133.57

135.73

g/l

9.48

2223

23161

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

682

1.89

9.99

1.5

2.4

2.70

2.98

g/l

2.15

114

629

(3010813) Leukocytes [#/volume] in Blood

2243

23376

0.65

9.94

36.4

21.8

6.99

6.79

e9/l

3.51

2202

22884

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

143

807

1.82

9.94

8.9

4.4

24.42

24.74

mmol/l

0.52

135

762

(3026361) Erythrocytes [#/volume] in Blood

2243

23370

0.66

9.80

36.3

21.8

4.45

4.52

e12/l

9.19

2201

22882

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2243

23369

0.66

9.78

37.5

22.2

39.87

40.89

3.26

2221

23141

(3024471) HLA-A [Type]

3.80

9.77

1.1

1.0

—

(3035941) MCH [Entitic mass]

2243

23368

0.66

9.76

36.2

21.7

30.27

30.22

0.61

2225

23149

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2243

23367

0.66

9.73

36.2

21.7

90.73

90.59

0.71

2226

23149

(3007461) Platelets [#/volume] in Blood

2243

23360

0.66

9.58

36.5

21.8

252.65

253.58

e9/l

0.25

2208

22928

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

722

1.84

9.52

1.6

2.4

6.74

7.31

g/l

2.68

118

669

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

722

1.84

9.52

1.6

2.4

4.23

4.24

g/l

0.04

118

669

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1681

15181

1.32

9.47

5.4

3.2

52.25

43.69

u/l

3.79

1601

14442

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

484

2.02

9.37

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

655

1.87

9.29

2.4

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

722

1.83

9.23

1.6

2.4

3.59

3.72

g/l

0.35

117

668

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

353

2.19

9.19

1.3

2.91

4.46

u/ml

1.07

168

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

335

2.21

9.09

1.2

111.50

116.09

0.62

312

(36660697) Celiac disease serology panel - Serum

277

1899

1.51

9.00

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.50

8.76

1.1

1.2

—

(3013512) EKG study

781

6423

1.31

8.64

4.2

3.3

—

0.70

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

267

3787

0.67

8.63

2.9

3.2

0.64

0.76

ug/l

2.29

174

2406

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.40

8.61

1.5

1.4

—

0.82

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.78

8.59

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

784

6459

1.31

8.54

3.9

3.0

0.19

0.07

estimate

0.32

285

1951

(3035933) Granulocytes/Leukocytes in Blood

523

1.93

8.49

3.2

3.3

58.08

57.84

0.07

523

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

121

3.00

8.46

1.2

1.1

—

(3019225) pH of Specimen

260

1782

1.51

8.45

4.9

4.2

7.33

7.35

0.70

209

1312

(3017181) Myelocytes/Leukocytes in Blood

277

1927

1.49

8.38

4.9

4.6

0.90

0.94

0.13

563

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.32

8.34

1.2

—

(4195642) Thrombophilia screening test

336

2.15

8.23

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

210

2.46

8.16

6.6

2.8

11.66

10.63

mmol/l

1.11

205

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

286

2016

1.47

8.10

4.3

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

635

1.82

8.02

1.6

2.4

10.82

10.44

g/l

0.34

101

578

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

120

2.94

7.97

1.3

1.8

3.61

3.28

nmol/l

0.05

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

189

2.51

7.91

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

113

638

1.81

7.90

1.5

2.4

0.61

0.98

g/l

0.71

559

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

224

1510

1.53

7.87

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

138

2.78

7.81

1.1

1579.89

1558.69

miu/ml

0.03

138

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.47

7.80

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

185

2.51

7.75

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.88

7.70

2.1

3.2

29.32

29.71

umol/l

0.05

(3025159) Blasts/Leukocytes in Blood

267

1877

1.47

7.66

4.9

0.05

0.30

0.83

459

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

145

887

1.67

7.65

2.0

1.24

1.45

g/l

2.03

123

778

(3022725) Serotonin [Moles/volume] in Serum

18.40

7.60

1.3

2.3

850.36

806.83

nmol/l

—

(3021440) Promyelocytes/Leukocytes in Blood

263

1849

1.47

7.54

4.8

4.7

0.10

0.12

0.13

485

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.45

7.50

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

194

2.45

7.50

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

1.99

7.48

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.09

7.43

39.0

28.2

119.08

126.24

ug/l

0.25

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

195

2.44

7.43

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

192

2827

0.65

7.40

2.1

1.9

3.50

3.47

ratio

0.08

142

2113

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.66

7.38

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

111

637

1.78

7.37

1.1

2.93

4.39

eliau/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

190

2.45

7.34

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

230

1584

1.50

7.31

2.9

2.8

69.73

70.18

ml/min/173m2

0.06

113

648

(3021589) Normoblasts [#/volume] in Blood

1123

9818

1.26

7.30

15.3

10.8

0.00

e9/l

0.42

977

7977

(3002179) Metamyelocytes/Leukocytes in Blood

261

1844

1.46

7.30

4.4

0.76

0.70

0.14

536

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.84

7.28

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

100

559

1.82

7.25

1.4

2.3

0.00

0.02

g/l

1.27

506

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

199

2.39

7.12

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.57

7.10

1.6

3.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

163

2.54

7.10

1.1

116.10

112.16

pmol/l

0.17

163

(4198724) Urine methamphetamine measurement

123

2.79

7.06

1.7

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

378

1.99

7.05

1.4

1.2

—

(3017732) Neutrophils [#/volume] in Blood

364

2751

1.38

6.96

3.3

3.1

4.28

4.66

e9/l

0.71

318

2437

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

182

1205

1.55

6.96

1.9

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

519

4144

1.32

6.89

1.4

1.3

110.59

27.98

iu/ml

0.51

122

1214

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

432

3360

1.34

6.87

3.7

3.0

3.72

2.55

e6/l

1.06

234

1602

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

118

704

1.71

6.86

2.2

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

896

0.43

6.85

1.5

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

439

1.90

6.82

3.8

3.0

1.79

1.52

mmol/l

1.08

423

(3045683) HLA typing for celiac disease panel - Blood or Tissue

161

2.51

6.76

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

877

0.42

6.76

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1119

0.49

6.74

1.5

60.03

59.70

ug/l

0.02

942

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.23

6.69

1.3

1.4

120.30

115.81

nmol/l

0.06

(21494755) Public health laboratory ask at order entry panel

167

2480

0.65

6.69

1.3

—

(4268621) Lupus anticoagulant assay

264

2.15

6.62

2.4

2.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.06

6.62

1.4

4.2

6710.86

74.11

mg/l

0.48

(40768441) Liver Pathology biopsy report

157

2.51

6.60

2.4

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

153

987

1.59

6.56

2.7

3.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

226

2.24

6.55

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.04

6.53

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

762

8908

0.79

6.47

3.1

2.8

—

(3024869) Neuronal Ab [Presence] in Serum

5.70

6.44

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

137

866

1.62

6.40

2.0

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

122

750

1.66

6.36

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

242

2.17

6.36

1.8

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

179

1206

1.52

6.34

1.1

—

112.84

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.55

6.33

1.1

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

5.96

6.30

1.3

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

5.96

6.30

1.3

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

3.18

6.29

2.1

2.2

0.31

0.22

e9/l

0.28

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

9.27

6.28

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

862

0.44

6.23

1.4

1.5

1.36

1.27

0.39

623

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

125

778

1.64

6.22

2.4

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

520

1.78

6.18

1.4

1.3

1.14

4.18

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

404

1.88

6.16

1.0

1.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

286

2.05

6.13

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

286

2.05

6.13

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

286

2.05

6.13

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

286

2.05

6.13

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

574

1.74

6.12

1.9

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.68

6.12

1.2

1.42

1.24

iu/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

399

1.88

6.06

1.1

—

(3000494) Fungus identified in Specimen by Culture

343

2624

1.36

6.05

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

117

2.67

5.99

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.88

5.98

5.5

5.7

5.85

5.08

kpa

1.06

(3026389) Candida sp identified in Specimen by Organism specific culture

282

2.04

5.98

1.5

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

203

2.24

5.95

2.4

5.2

96.64

82.95

u/ml

0.12

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1046

0.51

5.95

1.5

1.35

1.13

ratio

0.79

623

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

112

2.70

5.92

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

15.04

5.90

1.7

4.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

403

1.86

5.89

1.2

1.1

40.73

1361.23

iu/ml

0.52

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

160

2.40

5.88

2.7

2.9

228.21

215.45

e6/l

0.15

138

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

462

1.80

5.86

1.4

1.1

6.00

16.38

au/ml

2.67

129

(3003129) Base excess in Capillary blood by calculation

211

2.20

5.85

2.9

2.3

-0.59

0.26

mmol/l

0.52

205

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

354

1.92

5.85

1.1

—

(40761536) Microorganisms panel - Urine sediment

253

1854

1.40

5.81

4.9

3.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1048

0.51

5.77

1.5

1.03

0.95

ratio

0.44

625

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1048

0.51

5.77

1.5

1.04

1.17

ratio

0.62

628

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

365

1.89

5.67

1.2

1.1

1.08

2.25

1.28

(3009508) Creatinine [Moles/volume] in Urine

807

6944

1.24

5.66

3.7

3.6

7.56

8.01

mmol/l

1.67

711

5989

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.53

5.63

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

7.53

5.63

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

579

4807

1.26

5.56

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

279

2094

1.37

5.55

3.7

2.5

31.20

60.46

u/l

0.68

242

1758

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1035

0.52

5.55

1.4

1.5

—

(4281824) Cell count and differential, peritoneal fluid

203

2.19

5.54

1.5

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

653

1.65

5.53

1.3

35.68

2.32

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

162

1102

1.50

5.51

2.1

2.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

554

1.70

5.50

1.9

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2203

21109

1.33

5.50

29.6

16.1

139.38

139.61

mmol/l

3.90

2182

20670

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

656

1.64

5.43

1.4

1.3

2.63

8.16

u/ml

1.25

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

2.08

5.43

1.8

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

512

1.72

5.38

1.4

2.3

0.00

g/l

-0.00

483

(40758558) Short blood count panel - Blood

751

6445

1.23

5.34

7.7

6.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

323

1.91

5.32

1.3

1.9

—

1582.86

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.93

5.30

1.0

1.2

87.88

93.33

0.61

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

137

2.43

5.29

2.8

2.9

39.90

42.70

0.37

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

2.33

5.26

2.6

2.8

618.26

558.75

e6/l

0.25

129

(3024522) Salmonella sp identified in Specimen by Organism specific culture

241

2.05

5.26

1.8

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.24

5.17

3.4

3.0

4.95

4.89

kpa

0.08

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.24

5.17

3.4

3.0

12.10

10.44

kpa

0.57

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

110

697

1.60

5.15

1.3

1.2

8.86

40.12

u/ml

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

313

1.91

5.13

1.1

1.2

—

3.75

—

(3016879) Cocaine [Presence] in Urine

181

1278

1.45

5.12

2.1

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1960

20542

0.80

5.12

5.1

4.5

1.38

1.45

mmol/l

10.11

1859

19308

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

4.86

5.11

3.3

3.5

48.87

45.15

umol/l

0.31

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

133

1955

0.66

5.08

1.5

1.6

818.20

1000.59

mu/l

2.52

111

1655

(3021879) Hepatitis B virus core Ab [Presence] in Serum

279

2124

1.35

5.08

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

232

2.05

5.01

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

232

2.05

5.01

1.7

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2203

21160

1.31

5.00

29.2

16.3

3.95

3.96

mmol/l

1.09

2177

20680

(3040151) Glucose [Moles/volume] in Capillary blood

226

2.05

4.97

3.6

5.9

9.32

6.81

mmol/l

0.43

189

(3005988) Vibrio sp identified in Specimen by Organism specific culture

233

2.04

4.96

1.7

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.90

4.95

1.6

1.7

1.85

4.38

mg/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.67

4.92

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

361

1.82

4.92

4.2

3.1

7.61

7.42

mmol/l

0.17

348

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

444

3619

1.27

4.92

3.3

2.9

1.25

1.15

e6/l

0.15

250

1867

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

420

1.76

4.92

1.5

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

150

2138

0.68

4.89

1.7

1.6

3.27

3.46

mmol/l

1.31

1440

(3018133) Calcium [Moles/volume] in Urine

3.35

4.88

2.2

2.3

2.41

2.51

mmol/l

0.09

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

414

1.76

4.86

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

407

1.77

4.85

1.7

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.72

4.85

1.5

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1999

20878

0.80

4.84

5.6

5.1

2.69

2.75

mmol/l

2.27

1893

19651

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

195

2.12

4.83

1.6

1.7

—

(3045424) Erythrocytes [Presence] in Urine

147

1009

1.48

4.82

2.2

2.1

0.04

0.00

estimate

0.45

339

(3052851) Hemolysis interference index of Serum or Plasma

537

1.66

4.80

3.4

3.0

2.04

1.89

index

0.08

296

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1975

20648

0.80

4.77

5.2

4.6

4.53

4.64

mmol/l

5.55

1873

19531

(3006922) Hepatitis E virus Ab [Presence] in Serum

170

2.19

4.75

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.43

4.74

4.7

2.8

4.00

833.79

ug/l

0.49

(3026493) Urate [Moles/volume] in Serum or Plasma

636

5422

1.23

4.73

3.2

2.8

341.10

338.70

umol/l

0.22

576

4833

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

138

939

1.50

4.73

2.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.80

4.71

1.2

1.6

81.17

93.32

nmol/24h

0.45

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

294

1.89

4.70

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

3.03

4.67

1.1

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

550

1.64

4.64

1.4

2.3

0.00

g/l

-0.00

484

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

414

5025

0.79

4.58

3.9

4.4

21.63

21.62

0.00

177

2366

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.98

4.55

1.6

2.4

73.24

69.95

ug/l

0.04

(3000764) Benzodiazepines [Presence] in Urine

188

1369

1.40

4.51

2.1

2.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.07

4.51

1.1

—

(3028300) Cannabinoids [Presence] in Urine

189

1378

1.40

4.51

2.2

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.83

4.49

1.8

2.3

—

(40758292) HTLV I+II Ab panel - Serum

3.42

4.46

1.0

1.3

—

(3027008) Opiates [Presence] in Urine

188

1373

1.40

4.44

2.1

—

(4034850) Laboratory test

615

1.58

4.34

15.0

8.8

—

(3022145) Colonoscopy Study observation

295

2320

1.31

4.30

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

275

1.87

4.28

3.2

2.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

158

2.17

4.28

13.1

14.0

0.64

0.63

mmol/l

0.13

141

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

363

1.75

4.27

1.4

1.3

41.50

33.67

u/l

0.21

307

(21494814) CD8 cells/Lymphocytes in Specimen

2.71

4.25

2.2

1.9

32.38

30.33

0.22

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

179

2.08

4.21

1.2

71.68

64.52

u/l

0.24

162

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

856

1.48

4.19

1.7

21.55

12.15

u/ml

0.61

225

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.75

4.18

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

457

3816

1.24

4.08

1.4

1.3

4.66

11.29

u/ml

1.90

174

1526

(3051611) Lipemic interference index of Serum or Plasma

168

2.10

4.07

3.6

3.3

14.96

13.61

index

0.38

109

(3030313) Adrenal Ab [Titer] in Serum

4.63

4.05

1.1

1.0

—

titre

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.35

4.04

1.0

1.2

0.58

0.69

umol/24h

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

548

0.45

4.02

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

325

1.77

4.02

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

385

1.71

4.02

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

533

1.60

3.98

1.4

1.2

62.81

44.47

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

6.45

3.98

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

103

686

1.52

3.96

2.5

3.7

50.69

2291.18

u/ml

0.90

585

(3045414) Leukocytes [Presence] in Urine

249

1937

1.32

3.94

2.1

2.0

0.07

0.01

estimate

0.53

430

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.64

3.89

1.0

1.5

81.64

94.40

0.96

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

300

1.78

3.84

1.2

1.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

323

1.75

3.82

2.7

4.0

1.91

1.27

0.64

297

(3027944) Amphetamines [Presence] in Urine

182

1358

1.37

3.81

2.2

2.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.54

3.80

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

588

1.55

3.78

3.0

3.5

42.56

64.37

mg/l

0.53

500

(3034860) Kappa light chains.free [Mass/volume] in Serum

588

1.55

3.78

3.0

3.5

62.79

56.47

mg/l

0.18

499

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

910

1.44

3.74

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

519

1.58

3.71

2.5

3.4

2.33

2.43

ratio

0.06

296

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

4.15

3.70

5.8

7.0

11.79

10.97

0.37

(3028717) Thiamine [Mass/volume] in Blood

3.73

3.59

1.1

1.2

61.15

65.97

ug/l

0.21

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.95

3.57

2.2

1.2

—

0.33

—

(3004616) Nuclear Ab [Presence] in Serum

271

1.79

3.54

1.3

1.2

—

(4035726) Immunohistochemistry procedure

221

1720

1.31

3.51

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.17

3.50

3.4

4.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

417

1.62

3.48

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

417

1.62

3.48

1.6

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

592

5152

1.19

3.45

2.0

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

377

0.39

3.44

1.6

1.7

—

(3037756) Immunofixation for Serum or Plasma

366

1.65

3.38

1.5

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

2.29

3.36

1.6

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

549

6292

0.84

3.34

4.2

5.3

1.70

2.67

ug/l

4.84

487

5692

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

102

2.27

3.29

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

544

1.52

3.26

4.1

3.9

66.19

62.23

0.87

528

(3020682) Albumin/Creatinine [Ratio] in Urine

698

6188

1.18

3.26

4.6

4.3

16.23

9.64

mg/mmol

1.64

479

3987

(3051651) Icteric interference index of Serum or Plasma

109

2.21

3.25

3.3

3.6

0.88

0.86

index

0.02

109

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

177

1.93

3.24

3.4

2.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.38

3.18

1.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1772

18515

0.86

3.09

30.1

18.0

333.02

332.89

g/l

0.23

1763

18394

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.59

3.04

1.7

2.2

18.47

16.42

umol/l

0.31

(40768800) Prostate Pathology biopsy report

397

0.45

3.03

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

175

1351

1.32

2.98

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

10.02

2.98

1.4

1.2

1.90

1.28

mg/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.86

2.98

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.41

2.97

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.41

2.97

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

2.19

2.93

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

288

1.68

2.92

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.9

1.5

—

(3008898) HLA-B27 [Presence]

128

949

1.37

2.86

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

227

1824

1.27

2.85

2.8

4.3

10.92

21.48

ug/l

0.91

186

1458

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2189

21265

1.21

2.85

25.3

14.3

21.96

23.49

mg/l

1.50

1938

17371

(3000034) Microalbumin [Mass/volume] in Urine

143

1.97

2.85

3.6

21.13

38.15

mg/l

0.59

109

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

371

1.58

2.76

2.0

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

152

1.92

2.75

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1037

0.68

2.74

1.1

1.52

g/l

0.03

1037

(3013139) Helicobacter pylori Ag [Presence] in Stool

189

1493

1.29

2.73

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

2.73

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

125

2.01

2.70

2.1

2.3

9.13

8.50

mmol/l

0.32

125

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

643

1.43

2.70

1.7

2.2

5.70

3.99

iu/l

0.20

280

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

153

1.91

2.70

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.01

2.70

2.2

4.8

—

(3042517) Benzodiazepines panel - Urine

3.46

2.69

4.7

2.7

—

(3050794) Legionella sp Ab [Presence] in Serum

4.22

2.67

1.3

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

390

1.55

2.67

1.2

—

(3012516) Albumin [Mass/volume] in Urine

680

6100

1.16

2.66

3.8

3.6

83.72

54.74

mg/l

1.55

466

4029

(42529406) Shigella sp [Presence] in Stool by Culture

604

1.44

2.65

1.2

—

(3044927) Protein electrophoresis panel - Urine

176

1.83

2.64

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

169

1.84

2.63

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

597

1.44

2.62

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

1.91

2.55

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

121

1.99

2.55

2.0

1.5

1.23

1.34

nmol/l

0.11

(3014051) Protein [Presence] in Urine by Test strip

705

6358

1.15

2.55

3.3

2.7

0.00

-0.00

107

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

469

1.48

2.52

1.5

1.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.23

2.51

1.0

53.61

0.05

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1284

0.72

2.51

1.5

1.4

—

(3004451) EKG impression Narrative

115

2.01

2.50

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

918

8438

1.14

2.50

2.3

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

105

774

1.37

2.47

1.5

1.6

0.41

9.75

iu/ml

0.48

125

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

596

1.42

2.47

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

366

1.54

2.46

2.4

3.8

43.29

1131.27

u/ml

0.93

344

(3003888) Timothy IgE Ab [Units/volume] in Serum

588

1.43

2.46

1.1

2.41

5.15

u/ml

2.64

343

(1761482) Bacteria [#/volume] in Urine by Culture

416

1.50

2.42

3.5

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

243

1.66

2.38

2.1

2.4

1.61

1.52

g/24h

0.05

145

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.04

2.35

1.0

0.01

0.06

u/ml

—

(40768446) Kidney Pathology biopsy report

2.15

2.34

2.4

1.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.10

2.32

2.6

2.3

160.11

150.79

nmol/l

0.13

(3020393) Adenovirus Ag [Presence] in Stool

2.95

2.28

2.5

1.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.62

2.27

1.3

4.1

—

(44813793) Dust mix specific IgE antibody measurement

156

1.80

2.25

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

106

1.99

2.25

1.2

33.14

20.27

u/l

0.51

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.90

2.25

1.9

2.4

108.29

140.83

ug/g

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1883

19457

0.88

2.25

4.4

3.9

1.34

1.26

mmol/l

4.31

1769

18158

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

142

1.84

2.23

1.6

2.0

2.68

1.79

u/field

0.30

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.56

2.21

1.0

1.1

—

mmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.69

2.20

1.0

1.1

—

(3033099) Centromere Ab [Titer] in Serum

2.69

2.20

1.4

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

420

3684

1.17

2.20

2.4

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

456

1.44

2.08

4.7

2.6

1.08

0.87

nmol/l

1.11

395

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

671

1.35

2.03

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

177

1.70

2.02

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.06

2.01

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

111

1.90

2.00

1.6

1.5

11.75

6.64

u/l

0.37

(3017569) Oxygen content in Arterial blood

111

1.90

2.00

2.0

2.7

16.40

16.54

0.06

111

(3000093) Morphology [Interpretation] in Blood Narrative

193

1.67

1.99

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

163

1.73

1.98

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

265

1.56

1.95

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.19

1.94

1.1

31.88

12.26

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

339

1.48

1.92

1.4

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.31

1.87

1.1

1.3

31.80

139.33

ug/l

—

(3034426) Prothrombin time (PT)

2.09

1.86

1.2

1.3

26.67

28.38

0.72

(1002224) Polysomnography panel

143

1153

1.25

1.84

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

206

1.61

1.83

2.3

4.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

214

1.60

1.82

1.1

2.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.17

1.82

2.6

4.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.58

1.80

2.0

1.2

1.19

mmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.76

1.79

1.1

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

208

1.59

1.77

1.2

1.1

22.59

15.75

u/ml

0.19

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.34

1.74

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.92

1.72

1.0

1.2

1.55

1.82

umol/24h

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.85

1.71

1.0

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2025

19738

1.13

1.68

6.9

5.2

2.00

1.86

mu/l

0.38

1929

18506

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

245

2110

1.18

1.64

2.1

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.03

1.64

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.44

1.64

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

443

3989

1.13

1.62

1.7

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

128

1037

1.25

1.61

2.2

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

1.68

1.61

1.8

1.4

82.75

78.83

umol/l

0.22

143

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.07

1.59

1.6

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2193

22321

0.87

1.58

16.3

11.0

28.86

26.19

u/l

3.87

2148

21766

(3000012) Reticulocyte production index

280

1.47

1.57

1.7

1.9

1.09

0.88

0.99

192

(3014133) Dog dander IgE Ab [Units/volume] in Serum

501

1.35

1.55

1.1

3.48

4.00

u/ml

0.11

254

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

356

1.41

1.54

1.1

3.39

2.27

eliau/ml

0.36

169

(3008401) Mugwort IgE Ab [Units/volume] in Serum

572

1.32

1.52

1.1

0.64

1.29

u/ml

0.84

263

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.34

1.52

4.8

3.0

104.00

99.87

g/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.60

1.51

1.1

1.0

0.10

0.05

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.60

1.51

6.0

6.8

15.71

46.84

ug/min

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

1.51

0.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

115

929

1.25

1.50

1.6

1.7

4.87

4.25

mg/l

0.27

673

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

283

1.46

1.50

1.8

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

824

0.75

1.49

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

575

1.31

1.48

1.2

1.1

1.49

1.83

u/ml

0.18

299

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

655

1.29

1.46

1.2

1.1

4.16

2.50

u/ml

0.34

359

(3017509) Phencyclidine [Presence] in Urine

2.50

1.45

1.6

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.50

1.45

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

196

1.54

1.43

1.5

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

444

4036

1.12

1.40

2.5

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

224

1947

1.17

1.37

2.8

2.3

11.78

12.61

nmol/l

0.64

195

1776

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.61

1.36

1.8

2.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.83

1.35

1.3

1.2

65.32

53.90

u/ml

0.17

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

288

2555

1.14

1.34

2.3

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.97

1.32

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

463

1.33

1.31

1.2

1.1

3.76

5.74

u/ml

0.58

211

(40757373) Influenza virus identified in Isolate

2.36

1.29

1.1

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.36

1.29

1.9

2.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

185

1.52

1.29

1.1

1.2

—

13.67

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

161

1.56

1.28

1.4

1.3

103.62

219.80

pmol/l

1.28

161

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.00

1.27

1.9

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

935

0.79

1.26

1.4

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

103

841

1.23

1.26

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

170

1.53

1.26

1.2

1.4

345.00

382.52

u/l

0.11

164

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

107

1.69

1.25

1.1

1.3

—

60.00

—

(44806071) Cardiolipin IgM antibody measurement

2.40

1.24

1.0

1.1

—

(3017704) Immunofixation for Urine

100

1.70

1.23

1.4

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.77

1.23

2.1

2.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.63

1.21

1.2

1.5

35.20

35.25

nmol/l

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

101

1.69

1.19

2.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

101

1.69

1.19

2.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

101

1.69

1.19

2.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

101

1.69

1.19

2.5

1.7

—

(3020650) Glucose [Presence] in Urine

1.75

1.19

1.7

1.8

0.00

0.03

estimate

0.49

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.75

1.19

4.2

0.87

1.14

0.47

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.50

1.15

1.8

4.8

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1793

18349

0.92

1.09

28.9

17.4

13.73

13.49

10.14

1785

18103

(3007542) Rye IgE Ab [Units/volume] in Serum

2.38

1.09

1.2

1.0

1.42

1.38

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.82

1.09

1.2

1.4

10.60

8.34

ug/l

0.72

(3019832) Treponema pallidum Ab [Presence] in Serum

398

3651

1.11

1.09

1.7

1.9

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.19

1.08

1.6

1.7

6.63

316005.58

nmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

291

0.65

1.07

2.5

3.9

21.11

30.13

u/ml

0.64

283

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

203

1.43

1.05

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

107

899

1.20

1.03

1.4

1.5

—

(3019174) dRVVT (LA screen)

2.28

1.03

1.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

106

1.61

1.02

1.2

1.1

326.46

190.78

iu/ml

0.39

106

(3002256) Pathology report gross observation

308

2798

1.11

1.02

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.89

1.01

2.6

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

222

1.40

1.00

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

441

1.28

0.98

1.1

1.0

0.69

0.22

u/ml

0.44

148

(3036071) Salmonella sp Ab [Titer] in Serum

1.63

0.97

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.77

0.94

1.0

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.65

0.94

1.1

1.42

35.31

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.89

0.94

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

720

0.80

0.91

1.3

1.5

68.42

60.08

ug/l

0.90

720

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

134

1.50

0.91

1.3

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

673

1.21

0.90

1.4

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

278

0.68

0.89

1.5

1.6

8.04

7.62

mmol/l

0.36

267

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

0.02

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

1.41

0.89

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

177

1.42

0.88

1.1

0.71

1.84

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

422

1.26

0.87

3.5

3.3

25.18

26.90

mg/l

0.15

287

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

119

1028

1.17

0.87

1.2

1.3

216.84

224.19

miu/ml

0.06

505

(3001556) Androgen free Index in Serum or Plasma

2.00

0.87

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.94

0.84

1.7

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

240

1.34

0.82

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

258

1.32

0.81

1.3

1.5

29.92

32.45

g/l

0.49

231

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

130

1.47

0.80

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.79

0.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.82

0.79

1.7

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

115

1.48

0.76

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

115

1.48

0.76

1.5

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.00

0.72

1.2

1.1

—

(4024509) Urine culture

104

905

1.16

0.72

2.2

1.8

—

(3013637) Mi-2 Ab [Presence] in Serum

1.61

0.72

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.61

0.72

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.61

0.72

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.61

0.72

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

109

1.47

0.71

1.1

1.0

23.76

12.07

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

118

1.44

0.69

4.9

7.5

8.05

164.38

ug/l

0.60

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

204

1.33

0.69

1.2

1.3

1.21

1.97

u/ml

0.27

118

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.85

0.68

1.0

1.4

20.40

1155.37

u/l

—

(40765096) Chromosome analysis panel by Banding

1.57

0.65

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

207

1.31

0.63

1.9

2.2

15.79

20.72

mg/l

0.30

(3015076) Soybean IgE Ab [Units/volume] in Serum

172

1.34

0.63

1.1

0.73

2.18

u/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1325

0.89

0.63

2.0

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2224

22444

0.93

0.61

29.5

17.7

77.94

75.79

umol/l

1.61

2203

22184

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

1.36

0.61

1.3

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.67

0.61

1.6

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

545

1.18

0.61

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1500

15301

0.95

0.60

3.8

3.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

299

1.24

0.59

2.7

3.4

0.90

0.82

nmol/l

0.50

240

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

447

1.19

0.57

1.6

1.8

—

(4211845) Urine protein measurement

0.57

0.56

2.4

2.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

168

1.31

0.55

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

834

8612

0.95

0.54

2.0

1.9

1.47

1.36

mmol/l

2.46

732

7432

(4146454) Self-monitoring of blood glucose

195

1.28

0.54

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2001

19776

1.06

0.53

5.3

4.6

5.89

5.83

mmol/l

0.99

1881

18373

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

260

0.77

0.52

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

145

0.69

0.50

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

248

2321

1.08

0.50

4.6

4.4

30.67

31.95

1.16

190

1614

(3034274) Bile acid [Moles/volume] in Serum --fasting

465

1.16

0.48

2.9

2.3

9.74

6.40

umol/l

0.63

342

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.40

0.48

2.4

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

516

0.85

0.47

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.46

0.46

2.7

1.8

—

(3045142) Bone marrow Pathology biopsy report

236

1.23

0.46

1.1

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

182

1.27

0.46

6.3

4.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

247

1.22

0.44

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.37

0.44

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

130

1.31

0.44

1.3

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

130

1.31

0.44

1.8

1.6

0.47

0.48

e9/l

0.10

130

(40768806) Pleura Pathology biopsy report

193

1.25

0.43

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

443

1.15

0.42

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.05

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

195

1.23

0.40

1.1

7.63

7.43

iu/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.47

0.40

1.0

1.3

0.32

2.92

mmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

45.28

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

316

3311

0.95

0.38

1.8

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

169

1.24

0.38

2.0

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.39

0.38

1.2

1.0

2.60

6.49

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.32

0.37

1.6

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

134

1244

1.08

0.37

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

0.65

0.35

2.4

2.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

489

1.13

0.35

1.4

1.5

68.62

161.29

pmol/l

1.82

476

(21494890) Protein electrophoresis panel - 24 hour Urine

190

1.21

0.34

3.6

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

181

1.22

0.34

1.1

0.51

3.45

u/ml

—

(4015189) Microbial culture of sputum

1.33

0.33

1.7

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

143

0.77

0.32

1.0

1.3

—

(3000330) Specific gravity of Urine by Test strip

103

954

1.08

0.31

3.0

1.02

ratio

0.98

862

(3042631) Mycobacterium sp identified in Specimen

267

1.16

0.31

2.1

2.7

—

(21494434) Karyotype in Bone marrow

193

1.19

0.30

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

441

1.11

0.28

2.9

2.4

121.49

137.25

ug/min

0.13

269

(3011897) Casein IgE Ab [Units/volume] in Serum

1.25

0.27

1.3

0.10

0.59

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

117

0.77

0.27

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

205

1.17

0.27

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

141

1.21

0.26

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

0.73

0.24

2.3

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.27

0.22

3.4

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.27

0.22

3.4

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.27

0.22

3.4

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

526

1.09

0.21

1.6

1.4

2.92

3.54

ug/l

0.56

487

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

384.00

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.1

—

172.08

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

6.6

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.13

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

20.57

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.5

—

0.61

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

202

1.14

0.20

1.5

1.6

62.43

56.92

0.24

130

(3023199) Leukocytes [#/volume] in Pleural fluid

222

1.13

0.19

1.2

1.4

2044.31

5799.08

e6/l

0.46

154

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

109

1.19

0.18

1.6

3.0

20.09

92.47

ug/l

0.50

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

206

0.87

0.18

1.3

1.6

22.52

882.29

pmol/l

—

(40768443) Skin Pathology biopsy report

847

1.05

0.16

1.3

1.2

—

(40768793) Breast Pathology biopsy report

486

1.07

0.16

1.2

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1938

19291

1.02

0.15

6.8

5.6

38.52

38.49

mmol/mol

0.06

1848

18229

(3000475) Leukocytes [#/volume] in Synovial fluid

470

0.94

0.14

1.4

1.6

9001.26

13563.96

e6/l

0.79

334

(3029396) Erythrocyte agglutination [Presence] in Blood

0.82

0.13

2.4

3.2

—

(3049717) Cytology report of Urine Cyto stain

688

0.96

0.10

2.0

2.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.09

0.09

1.4

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.04

0.09

2.0

1.2

138.80

138.95

mmol/l

—

(4133840) Spirometry

1.09

0.09

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.07

0.08

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.82

0.08

1.0

1.1

3.70

39.59

iu/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.14

0.08

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.08

0.08

1.1

1.8

39.71

40.59

g/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.12

0.07

3.0

4.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.88

0.06

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

532

1.03

0.06

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

532

1.03

0.06

1.3

1.1

—

(40768795) Lymph node Pathology biopsy report

193

0.93

0.06

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

711

7069

1.01

0.06

1.6

—

(3022621) pH of Urine by Test strip

169

1713

0.99

0.05

2.6

2.3

6.10

6.12

0.11

120

1133

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1998

20014

0.99

0.05

20.8

13.5

87.57

86.22

ml/min/173m2

1.82

1881

18297

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

382

0.97

0.04

1.4

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

105

0.95

0.00

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

185

1.03

0.00

1.2

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

198

1.01

0.00

1.2

1.4

309380.00

95348.93

e6/l

—

114

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

492

1.00

0.00

1.3

1.2

—

(44806420) Estimation of glomerular filtration rate

257

1.01

0.00

2.3

2.2

—

(3025130) Human papilloma virus identified in Specimen

447

1.01

0.00

2.0

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

204.17

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

170.67

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

7.84

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

7514.00

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

90.80

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

130

1.00

-0.00

3.7

1.2

11.08

8.09

mm/h

0.33

130

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

210

1.00

-0.00

1.5

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.07

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.97

-0.00

1.2

44.50

66.73

ug/l

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

370.20

—

(3047189) Immunofixation for 24 hour Urine

1.01

-0.00

1.4

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.86

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.01

-0.00

1.3

1.2

—

(3024263) Appearance of Synovial fluid

0.99

-0.00

2.4

1.7

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.94

-0.00

1.6

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CERCYST and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CERCYST	3.663 [3.19, 4.21]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.072

During the follow-up period (1.1.1998 — 31.12.2019), 1185 out of 5799 females with G6_CERCYST died.

Males

Parameter	HR [95% CI]	p-value
G6_CERCYST	3.775 [3.36, 4.24]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2063 out of 6201 males with G6_CERCYST died.

Mortality risk

Mortality risk for people of age

years, who have G6_CERCYST.

N-year risk	Females	Males
1	0.347%	0.85%
5	2.303%	4.934%
10	5.1%	11.518%
15	9.267%	21.045%
20	15.851%	33.472%

Relationships between endpoints

↥

Index endpoint: G6_CERCYST – Cerebral cysts

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cerebral cysts

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints